Dr. Glassberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
475 N 5th Street
Phoenix, AZ 85004Phone+1 602-827-2601- Is this information wrong?
Education & Training
- University of Miami/Jackson Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1985 - 1988
- University of Miami Leonard M. Miller School of MedicineClass of 1985
- Wellesley CollegeB.A., With Honors, 1980
Certifications & Licensure
- IL State Medical License 2022 - 2026
- FL State Medical License 1986 - 2026
- AZ State Medical License 2019 - 2024
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Emory Visiting Professor Department of Medicine, Division of Pulmonary and Critical Care, Emory University, 2015
- Dines Named Visiting Professor Mayo Clinic, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Oct 01
- STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2012 Jul 16
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2.Amik Sodhi, Katherine Cox-Flaherty, Meredith Kendall Greer, Tasnim I Lat, Yuqing Gao, Deepika Polineni, Margaret A Pisani, Ghada Bourjeily, Marilyn K Glassberg, Caroly...> ;Chest. 2023 Feb 1
- 17 citationsAnti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.Gerard J Criner, Frederick M Lang, Robert L Gottlieb, Kusum S Mathews, Tisha S Wang, Todd W Rice, Deepu Madduri, Shashi Bellam, Robert Jeanfreau, Amy H Case, Marilyn K...> ;American Journal of Respiratory and Critical Care Medicine. 2022 Jun 1
- 1 citationsAssociation of Women Leaders with Women Program Director and Trainee Representation Across US Academic Internal Medicine.Kantha Medepalli, Stefanie Purdon, Rebecca M Bade, M K Glassberg, Ellen L Burnham, Hayley B Gershengorn> ;Journal of General Internal Medicine. 2023 Jan 1
- Join now to see all
Journal Articles
- Sensitivity Analyses of the Change in Forced Vital Capacity in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisLederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE Jr, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW, Chest, 1/9/2015
- Pulmonary Complications of Inflammatory MyopathyMiller SA, Glassberg MK, Ascherman DP, Rheum Dis Clin North Am, 1/1/2015
- A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisKing TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sa..., N Engl J Med, 1/29/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G., Glassberg MK, et al, N Engl J Med, Idiopathic Pulmonary Fibrosis Clinical Research Network, 1/29/2014
- Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical tr...Saketoo LA, Mittoo S, Huscher D, Khanna D, Deallaripa PF, Distler O, Flasherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Boelecka OM, Glassberg MK, et al, Thorax, 1/28/2014
- Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Glassberg MK, et al, Ann Intern Med, 1/7/2013
- Join now to see all
Lectures
- "Idiopathic Pulmonary Fibrosis: Raising the Index of Suspicion in Primary Care"Princeton , NJ - 1/30/2015
- "Stem Cell Therapy in Interstitial Lung Disease"Miami Beach, FL - 1/23/2015
- "A new era in IPF: using cell-based therapies in chronic lung disease"Palm Beach, FL - 1/13/2015
- Join now to see all
Other
- Proactive and comprehensive management of patients with IPF.Glassberg MK, Rosen G, Staton G
https://www.ipfrally.com/managing-the-ipf-patient
1/1/2014 - Targeting the Pathophysiology of Idiopathic Pulmonary Fibrosis: Inhibiting Fibrogenetic Processes.Glassberg MK
http://www.quintilesmeded.com/inhibitingIPF
1/1/2013 - Current and Investigational Treatment Options for IPF.Glassberg MK, Point of Care360: Idiopathic Pulmonary Fibrosis Edition
http://www.Projectknowledge.com
1/1/2013 - Join now to see all
Press Mentions
- UArizona Health Sciences Researchers to Study Long COVID as Part of National CollaborativeNovember 22nd, 2021
- Optimism and Caution Lead the Way in Stem Cell Therapy Research for COPDJuly 9th, 2021
- The Arizona RepublicMay 5th, 2021
- Join now to see all
Hospital Affiliations
- Banner - University Medical Center PhoenixPhoenix, Arizona
- Loyola University Medical CenterMaywood, Illinois
External Links
- university of miamihttp://med.miami.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: